Results 141 to 150 of about 4,131,311 (354)

Development of a Calculator For Medical Student Residency Applications [PDF]

open access: yes, 2017
This poster describes an attempt to create an evidence-based approach to advising medical students with regard to the number of family medicine residency programs to which they need to ...
Crossman, Steven H.
core   +2 more sources

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

open access: yesMolecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués   +3 more
wiley   +1 more source

The contributions of family medicine research [PDF]

open access: yes, 2005
published_or_final_versio
Lam, CLK
core  

South Africa has joined a global initiative for Family Medicine advocacy [PDF]

open access: gold, 2015
Klaus B. Von Pressentin   +2 more
openalex   +1 more source

Common adolescent mental health disorders seen in Family Medicine Clinics in Ghana and Nigeria

open access: gold, 2023
Sonny John Kumbet   +8 more
openalex   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy